Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
Journal of the American College of Clinical Pharmacy : JACCP|February 5, 2019
Pharmacist-Led, Technology-Assisted Study to Improve Medication Safety, Cardiovascular Risk Factor Control, and Racial Disparities in Kidney Transplant RecipientsDavid J Taber, Mulugeta Gebregziabher, Aurora Posadas, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 18, 2024
Disparities in Access to Valganciclovir Cytomegalovirus Prophylaxis in High-Risk African American Kidney Transplant PatientsShipra R Bethi, David J Taber, Erika Andrade, et al.
Clinical Transplantation|October 31, 2025
Improved LCP Tacrolimus XR Dosing and Monitoring Outcomes With a Genotype-Based Dosing Algorithm Versus Weight Based DosingChristine S Wolesensky, Neha Patel, Santosh Nagaraju, et al.
Pharmacotherapy|October 27, 2020
The impact of pretransplant opioid exposure on healthcare utilization and costs in kidney transplantBailey Wise, Lytani Z Wilson, David J Taber, et al.
Health Equity|October 3, 2019
Racial-Geographic Disparity in Lipid Management in Veterans with Type 2 Diabetes: A 10-Year Retrospective Cohort StudyElizabeth A Brown, Ralph C Ward, Erin Weeda, et al.
The Annals of Pharmacotherapy|February 7, 2019
The Impact of Dual Health Care System Use for Obtaining Prescription Medications on Nonadherence in Veterans With Type 2 DiabetesDavid J Taber, Ralph Ward, R Neal Axon, et al.
Journal of Managed Care & Specialty Pharmacy|August 29, 2020
An Evaluation of Statin Use Among Patients with Type 2 Diabetes at High Risk of Cardiovascular Events Across Multiple Health Care SystemsRalph Ward, Erin R Weeda, Kinfe G Bishu, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 31, 2019
Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipientsDavid J Taber, Nicole A Pilch, John W McGillicuddy, et al.
Pageof 17